Novel drug targets tumor growth in advanced kidney cancer

Harvard researchers at Dana-Farber Cancer Institute have developed a novel targeted drug that shows promise in advanced kidney cancer by interfering with the abnormal blood vessel formation that fuels tumor growth.

Richard Saltus • harvard
Feb. 12, 2020 ~4 min

Tags:  nobel-prize  basic-research  health-medicine  dana-farber-cancer-institute  tumors  clear-cell-renal-cell-carcinoma  hypoxia-inducible-factor  kidney-cancer  metastatic-disease  mk-6482  phase-iii  toni-choueiri  william-g-kaelin-jr

Page 1 of 1